TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27216329

Group type: EXPERIMENTAL
Intervention: Parent training (PEP-PA) for children with severe ADHD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teacher training (PEP-TE) for children with severe ADHD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parent training (PEP-PA) for children with no or mild ADHD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teacher training (PEP-TE) for children with no or mild ADHD
Number of subjects: 0
Study: 24003241

Group type: EXPERIMENTAL
Intervention: Guaifenesin (GGE) 600 mg extended-release tablets, taken twice daily for 8 days
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 22138342

Group type: EXPERIMENTAL
Intervention: FDG PET-assisted management
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Adherence to FDG PET recommendations
Number of subjects: 430

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 430
Study: 19930235

Group type: EXPERIMENTAL
Intervention: Oral Naltrexone + Brief Behavioral Compliance Enhancement Therapy (BBCET) + treatment as usual (TAU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief Counseling Intervention (BCI) + TAU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naltrexone + BBCET + BCI + TAU
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 0
Study: 17984668

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 2334

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 2334
Study: 16020621

Group type: EXPERIMENTAL
Intervention: Community involvement in data collection roles
Number of subjects: 0
Study: 12390317

Group type: EXPERIMENTAL
Intervention: Protease Inhibitor (PI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between NNRTI and PI cohorts
Number of subjects: 0

Group type: COMPARATOR
Intervention: CCR5 expression
Number of subjects: 0

Group type: COMPARATOR
Intervention: CCR5 Delta32 genotyping
Number of subjects: 0
Study: 9813869

Group type: EXPERIMENTAL
Intervention: Exercise training (40 min of supervised exercise every other day at 70% of heart rate reserve for 10 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonexercise control (NEX)
Number of subjects: 50
Study: 8749873

Group type: COMPARATOR
Intervention: Dipyridamole alone (group 1, controls, n = 6)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dipyridamole and diltiazem (group 2, n = 5)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dipyridamole and diltiazem (group 3, n = 5)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diltiazem (10 mg) intravenous administration
Number of subjects: 16
Study: 1977380

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 38969

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31488485

Group type: COMPARATOR
Intervention: EPA schools (n=154)
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Non-EPA schools (n=788)
Number of subjects: 1607

Group type: COMPARATOR
Intervention: EPA schools (primary teachers)
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Non-EPA schools (primary teachers)
Number of subjects: 1607
Study: 28973363

Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver and PEEP titration according to best respiratory-system compliance (n=501)
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver and PEEP titration (n=501)
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Low PEEP (n=509)
Number of subjects: 1010
Study: 26529014

Group type: EXPERIMENTAL
Intervention: BoNTA at acupoint-sites (2.5 U each site, 25 U per subject)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: BoNTA at fixed-sites (2.5 U each site, 25 U per subject)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 23912836

Group type: EXPERIMENTAL
Intervention: AT-877ER
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21876879

Group type: EXPERIMENTAL
Intervention: Semipermeable membrane
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study: 19969213

Group type: EXPERIMENTAL
Intervention: LASIK with superior hinge position
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: LASIK with temporal hinge position
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: LASIK with 45-degree hinge angle
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: LASIK with 90-degree hinge angle
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: LASIK with 100 microm flap thickness
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: LASIK with 130 microm flap thickness
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: LASIK (all groups)
Number of subjects: 190
Study: 16453956

Group type: EXPERIMENTAL
Intervention: Immediate removal via rigid endoscopy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Observation for 16 hours with repeat x-ray
Number of subjects: 60

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 60
Study: 14978636

Group type: EXPERIMENTAL
Intervention: Dietary changes, use of laxatives, cognitive and behavioral interventions (toilet training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antidiarrheal agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anorectal biofeedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged use of enemas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery for congenital anorectal anomalies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continent appendicostomy (Malone procedure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cecostomy
Number of subjects: 0
Study: 11759935

Group type: EXPERIMENTAL
Intervention: Carotid artery intima-media thickness greater than 0.8 mm
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Hypertensive group with coronary artery disease
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Diabetics with concomitant hypertension
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Carotid artery intima-media thickness
Number of subjects: 266
Study: 9387948

Group type: EXPERIMENTAL
Intervention: Nasal eupnoeic inhalation of cold dry air (‐5 degrees C)
Number of subjects: 40
Study: 8110915

Group type: EXPERIMENTAL
Intervention: CMI challenge followed 2 weeks later by CMI rechallenge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo challenge followed 2 weeks later by CMI challenge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CMI challenge followed 4 weeks later by CMI rechallenge
Number of subjects: 0
Study: 3099442

Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 28

Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 28
Study: 30559807

Group type: EXPERIMENTAL
Intervention: Diet therapy for three months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no diet therapy)
Number of subjects: 67
Study: 25712086

Group type: EXPERIMENTAL
Intervention: Group 1 - one long instrument, one standard length instrument and standard length laparoscope
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control - standard length instruments and standard length laparoscope
Number of subjects: 23
Study: 23592701

Group type: EXPERIMENTAL
Intervention: Early thoracic radiotherapy (TRT) administered concurrently with the first cycle of chemotherapy
Number of subjects: 222

Group type: COMPARATOR
Intervention: Late thoracic radiotherapy (TRT) administered concurrently with the third cycle of chemotherapy
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Early TRT
Number of subjects: 222

Group type: COMPARATOR
Intervention: Late TRT
Number of subjects: 222
Study: 20118149

Group type: EXPERIMENTAL
Intervention: Thrombectomy
Number of subjects: 4299

Group type: EXPERIMENTAL
Intervention: Simple aspiration thrombectomy
Number of subjects: 4299
Study: 18502484

Group type: COMPARATOR
Intervention: Standard Snodgrass urethroplasty
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mathieu‐Incised Plate (Mathieu‐IP) technique
Number of subjects: 40
Study: 15900994

Group type: EXPERIMENTAL
Intervention: Greater academic incentive reward structure
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard academic reward structure (control group)
Number of subjects: 210
Study: 12559643

Group type: EXPERIMENTAL
Intervention: Five courses of therapy
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Four courses of therapy
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Five courses of therapy (early results)
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Four courses of therapy (early results)
Number of subjects: 1078
Study: 10698464

Group type: EXPERIMENTAL
Intervention: Xanthium
Number of subjects: 12

Group type: COMPARATOR
Intervention: Theo-Dur
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 12
Study: 7847530

Group type: EXPERIMENTAL
Intervention: Norplant contraceptive implants (immediate insertion within 48 hours of delivery)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (Norplant insertion at 4- to 6-week postpartum visit)
Number of subjects: 250
Study: 1942508

Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg.kg‐1 + 10 ml saline
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg.kg‐1 + 10 ml saline
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline only (10 ml)
Number of subjects: 21
Study: 6798624

Group type: EXPERIMENTAL
Intervention: Alcohol with monetary and performance feedback reinforcement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol without reinforcement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol with withdrawal of reinforcement
Number of subjects: 0
Study: 31157368

Group type: EXPERIMENTAL
Intervention: Intervention clinics
Number of subjects: 6836

Group type: EXPERIMENTAL
Intervention: Community mobilization meetings
Number of subjects: 6836

Group type: COMPARATOR
Intervention: Overall HIV care continuum
Number of subjects: 6836

Group type: COMPARATOR
Intervention: National priority for HIV testing and treatment
Number of subjects: 6836
Study: 28231325

Group type: EXPERIMENTAL
Intervention: High intensity exercise (80% of maximal perceived exertion)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Low intensity exercise (50% of maximal perceived exertion)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: High intensity exercise
Number of subjects: 76

Group type: COMPARATOR
Intervention: Low intensity exercise
Number of subjects: 76
Study: 25877498

Group type: EXPERIMENTAL
Intervention: Brodalumab 70 mg
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Brodalumab 140 mg
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Brodalumab 210 mg
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 23910617

Group type: EXPERIMENTAL
Intervention: IVIG (400mg/kg/day for 5 consecutive days)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: IVIG (two courses)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo followed by IVIG (single course)
Number of subjects: 63
Study: 21368658

Group type: EXPERIMENTAL
Intervention: External drainage stent
Number of subjects: 158

Group type: COMPARATOR
Intervention: No stent
Number of subjects: 158
Study: 19107974

Group type: EXPERIMENTAL
Intervention: HIV-1 seroconversion
Number of subjects: 104
Study: 17156223

Group type: EXPERIMENTAL
Intervention: PEEP at 8 cmH(2)O
Number of subjects: 46

Group type: COMPARATOR
Intervention: PEEP at 0, 5, or 10 cmH(2)O
Number of subjects: 46
Study: 15015438

Group type: EXPERIMENTAL
Intervention: Combination of Bushen Jianpi Recipe (BJR) and low dosage erythropoietin (EPO) - 50 IU/kg subcutaneous injection twice a week and oral intake of BJR, one dose per day for 3 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erythropoietin (EPO) alone - 50 IU/kg subcutaneous injection three times a week for 3 months.
Number of subjects: 0
Study: 11224632

Group type: EXPERIMENTAL
Intervention: Islet autotransplantation (IAT) combined with total pancreatectomy (TP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Total pancreatectomy (TP) alone
Number of subjects: 24
Study: 9395702

Group type: EXPERIMENTAL
Intervention: Chiropractors
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Acupuncturists/Traditional Chinese Medicine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Naturopaths
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Reiki practitioners
Number of subjects: 300

Group type: COMPARATOR
Intervention: Family physicians
Number of subjects: 300
Study: 7933527

Group type: EXPERIMENTAL
Intervention: Biapenem (L-627) 6 mg/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Biapenem (L-627) 12 mg/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Biapenem (L-627)
Number of subjects: 36
Study: 3125800

Group type: COMPARATOR
Intervention: Intravenous feeding (IVF) alone
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 1 hour of submaximal (51% of VO2max) stationary bicycle exercise daily during IVF
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Submaximal exercise
Number of subjects: 14
Study: 31823130

Group type: EXPERIMENTAL
Intervention: Dotinurad (1 mg) administered orally
Number of subjects: 3
Study: 28930490

Group type: EXPERIMENTAL
Intervention: Tezacaftor (100 mg every day) and ivacaftor (150 mg every 12 h)
Number of subjects: 0
Study: 28625368

Group type: EXPERIMENTAL
Intervention: Aspirin 100mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25987611

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24028813

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus capecitabine (n=140)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Capecitabine alone (n=140)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus capecitabine
Number of subjects: 280
Study: 20869774

Group type: EXPERIMENTAL
Intervention: Amblyopia diagnosis
Number of subjects: 6830

Group type: EXPERIMENTAL
Intervention: Underlying causes of amblyopia
Number of subjects: 6830
Study: 18214943

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg elemental Zn daily for 1 year)
Number of subjects: 26
Study: 17030773

Group type: EXPERIMENTAL
Intervention: Lamotrigine monotherapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Lamotrigine in combination with valproate
Number of subjects: 14

Group type: COMPARATOR
Intervention: Users of oral contraceptives comedicated with valproate
Number of subjects: 14
Study: 14646388

Group type: EXPERIMENTAL
Intervention: ebastine 20 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: fexofenadine 120 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 10966901

Group type: EXPERIMENTAL
Intervention: TPN enriched with glutamine dipeptides (60 micromol glutamine*kg body wt(‐1)*h(‐1))
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard TPN solution (glutamine-free)
Number of subjects: 23
Study: 9007124

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 as a 3-hour infusion followed by carboplatin at a dose based on a target area under the concentration-time curve of 6 mg x min/mL.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate surgery after two courses of neoadjuvant chemotherapy for responding patients.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two courses of neoadjuvant chemotherapy for nonresponders before surgery.
Number of subjects: 0
Study: 1593361

Group type: EXPERIMENTAL
Intervention: Loracarbef
Number of subjects: 284

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate
Number of subjects: 284
Study: 6376714

Group type: EXPERIMENTAL
Intervention: Endarterectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31608900

Group type: EXPERIMENTAL
Intervention: Soft tissue manipulation techniques including post-isometric muscle relaxation, myofascial relaxation, and Swedish massage limited to the cervicothoracic complex
Number of subjects: 90

Group type: COMPARATOR
Intervention: Jacobson's progressive relaxation
Number of subjects: 90
Study: 29061183

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) group (FG) supplemented with 2 g/day of FO concentrate containing 1.8 g of n-3 fatty acids for 30 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group (PG) received 2 g/day of mineral oil
Number of subjects: 0
Study: 26428314

Group type: EXPERIMENTAL
Intervention: Problem Management Plus (PM+)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 346
Study: 23368724

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-touch intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 21263414

Group type: EXPERIMENTAL
Intervention: Continuous infusion of proton pump inhibitors (PPIs)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard regimen (40 mg bolus twice a day for 3 days) of proton pump inhibitors (PPIs)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard regimen of PPIs
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Continuous infusion of PPIs
Number of subjects: 69
Study: 19656244

Group type: EXPERIMENTAL
Intervention: Robotic navigation system (RNS)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Manual ablation
Number of subjects: 390
Study: 17366253

Group type: EXPERIMENTAL
Intervention: Prize-based incentives plus treatment as usual (TAU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 0
Study: 15545559

Group type: EXPERIMENTAL
Intervention: Crosseal fibrin sealant
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard topical hemostatic agents
Number of subjects: 121
Study: 11273851

Group type: EXPERIMENTAL
Intervention: Low-dose vitamin B-6 (1.6 mg/d) for 12 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Folic acid (400 microg/d for 6 weeks)
Number of subjects: 22
Study: 9500719

Group type: EXPERIMENTAL
Intervention: IFN-alpha2a 3 million units three times per week + Tenoxicam (20 mg/day) during 6 months
Number of subjects: 149

Group type: COMPARATOR
Intervention: IFN-alpha2a 3 million units three times per week + placebo during 6 months
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Both groups (G1 and G2)
Number of subjects: 149
Study: 7850042

Group type: EXPERIMENTAL
Intervention: Rehab program (n = 11) - comprehensive exercise program with balance retraining and goal-directed eye-head exercises, 45-minute sessions, three times per week for 12 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Home program (n = 12) - Cooksey-Cawthorne eye-head exercises performed at home daily for 12 weeks
Number of subjects: 23
Study: 3416548

Group type: EXPERIMENTAL
Intervention: Vitamin A cream (1,000 IU/g)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control cream (without vitamin A)
Number of subjects: 114
Study: 31911522

Group type: EXPERIMENTAL
Intervention: Transition Clinic (TC)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Direct handover care (Control)
Number of subjects: 110
Study: 31369180

Group type: EXPERIMENTAL
Intervention: DACC‐coated cotton acetate dressing
Number of subjects: 14

Group type: COMPARATOR
Intervention: Combination of normal saline dressing and 2% mupirocin ointment
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 28972194

Group type: EXPERIMENTAL
Intervention: Participants with metabolic syndrome
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Participants without metabolic syndrome
Number of subjects: 1022
Study: 23241065

Group type: EXPERIMENTAL
Intervention: Dietary recommendations (10 specific dietary recommendations); dietary score from 0 to 10 based on adherence
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Subscales of dietary recommendations
Number of subjects: 154
Study: 23442750

Group type: EXPERIMENTAL
Intervention: Retrograde light-guided laryngoscopy (RLGL)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conventional direct laryngoscopy (DL)
Number of subjects: 205
Study: 22082702

Group type: EXPERIMENTAL
Intervention: Knowledge and Behavior (K&B) therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional therapy (Control)
Number of subjects: 77
Study: 18823530

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 500

Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 500
Study: 16942454

Group type: EXPERIMENTAL
Intervention: Wearing a splint holding the ankle in maximum dorsiflexion nightly for 6 weeks
Number of subjects: 14
Study: 12901447

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement (ME)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Brief Advice (BA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 45
Study: 10680808

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 105
Study: 9310898

Group type: EXPERIMENTAL
Intervention: Suboccipital stretching technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peripheral stretching technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham/placebo
Number of subjects: 60
Study: 8377718

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Diuretic (hydrochlorothiazide and triamterene)
Number of subjects: 47
Study: 2854738

Group type: EXPERIMENTAL
Intervention: ACTH therapy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Prednisone therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: ACTH or Prednisone therapy
Number of subjects: 16
Study: 29483842

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Kinesiotherapy (KT)
Number of subjects: 0
Study: 27561415

Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation along with usual care (n=25)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care alone (n=28)
Number of subjects: 53